Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis

NCT01701856 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER_GOV

Sponsor class

Stopped Problems to recruit the needed number of patients in the planned time

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: Interferon beta-1b

Sponsor

Claudio Gobbi

Collaborators

[object Object]